Type 2 diabetes candidate genes, including PAX5, cause impaired insulin secretion in human pancreatic islets
Both are GLP-1 receptor agonists used to help manage type 2 diabetes and, in some cases, to support weight loss under medical supervision
Study participants We identified all adult (aged 20 years) patients with NAFLD and type 2 diabetes who had newly started treatment with non-insulin glucose-lowering drugs (metformin, GLP-1RAs, SGLT2 inhibitors, sulfonylureas, meglitinides, thiazolidinediones, acarbose or dipeptidyl peptidase-4 inhibitors) between 1 January 2013 and 31 December 2021
However, consult with your doctor if you experience any side effects as the leniency may worsen the condition
Shaking the vial can damage the delicate peptide chains through a process called denaturation
What are the evidence-based options for muscle preservation in the UK